Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
19
NMPA:19
Drug Approvals
Phenylephrine Hydrochloride Injection
- Product Name
- 盐酸去氧肾上腺素注射液
- Approval Number
- 国药准字H20249726
- Approval Date
- Dec 10, 2024
NMPA
Rocuronium Bromide Injection
- Product Name
- 罗库溴铵注射液
- Approval Number
- 国药准字H20249665
- Approval Date
- Dec 1, 2024
NMPA
Ozagrel Sodium for Injection
- Product Name
- 注射用奥扎格雷钠
- Approval Number
- 国药准字H20058332
- Approval Date
- Aug 6, 2024
NMPA
Ozagrel Sodium for Injection
- Product Name
- 注射用奥扎格雷钠
- Approval Number
- 国药准字H20058331
- Approval Date
- Aug 6, 2024
NMPA
Ozagrel Sodium for Injection
- Product Name
- 注射用奥扎格雷钠
- Approval Number
- 国药准字H20058330
- Approval Date
- Aug 6, 2024
NMPA
Compound Diisopropylamine Dichloroacetate for Injection
- Product Name
- 注射用复方二氯醋酸二异丙胺
- Approval Number
- 国药准字H20060914
- Approval Date
- Aug 6, 2024
NMPA
Glucosamine Sulfate Capsules
- Product Name
- 硫酸氨基葡萄糖胶囊
- Approval Number
- 国药准字H20244454
- Approval Date
- Jul 16, 2024
NMPA
Esomeprazole Sodium for Injection
- Product Name
- 注射用艾司奥美拉唑钠
- Approval Number
- 国药准字H20217040
- Approval Date
- Jun 8, 2023
NMPA
Esomeprazole Sodium for Injection
- Product Name
- 注射用艾司奥美拉唑钠
- Approval Number
- 国药准字H20183387
- Approval Date
- Jun 8, 2023
NMPA
- Prev
- 1
- 2
- Next
Clinical Trials
No trials found
News
No news found